MANDIE HAGGART: Open Payments
NPI 1821661430 · LECOMPTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,221 in 22 payments from 11 companies in 2025. Trend: 2023 $236 · 2024 $1,034 · 2025 $1,221
Food & beverage: $1,221
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $232 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $230 |
| Axsome Therapeutics, Inc. | 4 | $177 |
| Abbott Laboratories | 2 | $155 |
| Astellas Pharma US Inc | 1 | $129 |
| Ardelyx, Inc. | 1 | $124 |
| PFIZER INC. | 1 | $94 |
| SCPHARMACEUTICALS INC. | 1 | $24 |
| Corium, LLC | 1 | $20 |
| Indivior Inc. | 1 | $19 |
Products named: VRAYLAR, XIFAXAN, Auvelity, FREESTYLE LIBRE 3, Veozah, IBSRELA, NURTEC ODT, FUROSCIX.
Industry payments across LA — which companies pay providers there.
